𝔖 Bobbio Scriptorium

✦ LIBER ✦

Would riluzole be efficacious in the new ALS trial design?

✍ Scribed by Esther Verstraete; Jan H Veldink; Leonard H van den Berg

Book ID: 114409625
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 51 KB
Volume: 9
Category: Article
ISSN: 1474-4465
DOI: 10.1016/s1474-4422(10)70230-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Would riluzole be efficacious in the new

Would riluzole be efficacious in the new ALS trial design? – Authors' reply

✍ Swati Aggarwal; Lorne Zinman; David Schoenfeld; Jeremy Shefner; Merit Cudkowicz 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 50 KB

Efficacy of the trial-based thought reco

Efficacy of the trial-based thought record, a new cognitive therapy strategy designed to change core beliefs, in social phobia

✍ I. R. de Oliveira; V. B. Powell; A. Wenzel; M. Caldas; C. Seixas; C. Almeida; T. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

Trial finds that enoxaparin may be the p

Trial finds that enoxaparin may be the preferred drug for initiating anticoagulation in atrial fibrillation: Abstracted from: Stellbrink C, Nixdorff U, Hofmann T, et al. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial. Circulation 2004; 109: 997-1003.

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 126 KB